187 related articles for article (PubMed ID: 37865504)
1. Morphologic Characteristics of Myelodysplastic Syndromes.
Yuen LD; Hasserjian RP
Clin Lab Med; 2023 Dec; 43(4):577-596. PubMed ID: 37865504
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP; Germing U; Malcovati L
Blood; 2023 Dec; 142(26):2247-2257. PubMed ID: 37774372
[TBL] [Abstract][Full Text] [Related]
4. The current approach to the diagnosis of myelodysplastic syndromes
Weinberg OK; Hasserjian RP
Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
[TBL] [Abstract][Full Text] [Related]
5. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
7. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations.
Ng AP; Adams R; Tiong IS; Seymour L; Talaulikar D; Palfreyman E; Enjeti A; Tate C
Pathology; 2024 Jun; 56(4):459-467. PubMed ID: 38580613
[TBL] [Abstract][Full Text] [Related]
8. Impact of the International Consensus Classification of myelodysplastic syndromes.
Zhang Y; Wu J; Xu Z; Qin T; Qu S; Pan L; Wang H; Sun Q; Li C; Jia Y; Cai W; Yan X; Gong J; Gao Q; Li B; Gale RP; Xiao Z
Br J Haematol; 2023 May; 201(3):443-448. PubMed ID: 36575970
[TBL] [Abstract][Full Text] [Related]
9. [Morphologic diagnosis of myelodysplastic syndromes].
Matsuda A
Rinsho Ketsueki; 2017; 58(4):336-346. PubMed ID: 28484164
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Yu SC; Liu MC; Yuan CT; Yang YT; Chuang MK; Ko BS; Tang JL; Sun HI; Chuang YK; Tien HF; Hou HA; Chou WC
Blood Cancer J; 2024 Apr; 14(1):57. PubMed ID: 38594285
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndromes.
Zhou J; Orazi A; Czader MB
Semin Diagn Pathol; 2011 Nov; 28(4):258-72. PubMed ID: 22195404
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy.
Delacrétaz F; Schmidt PM; Piguet D; Bachmann F; Costa J
Am J Clin Pathol; 1987 Feb; 87(2):180-6. PubMed ID: 3812349
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
14. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of dysplasia characteristics in typing of myelodysplastic syndrome].
Li J; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):657-61. PubMed ID: 23815917
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
Bennett JM
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
[TBL] [Abstract][Full Text] [Related]
17. [Pathohistological characteristics of myelodysplastic syndromes: diagnostic and prognostic significance].
Marisavljević D; Cemerikić V; Rolović Z; Bosković D; Colović M
Srp Arh Celok Lek; 2005; 133(3-4):162-9. PubMed ID: 16206706
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics and Prognostication of Myelodysplastic Syndromes.
Zini G
Ann Lab Med; 2017 Nov; 37(6):465-474. PubMed ID: 28840983
[TBL] [Abstract][Full Text] [Related]
19. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
[TBL] [Abstract][Full Text] [Related]
20. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]